News | RIVM

Vaccines very effective against hospital and ICU admissions, also for Delta variant

COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.

Uit onderzoek naar de effectiviteit van de COVID-19-vaccins tegen ziekenhuis- en IC-opname blijkt dat ziekenhuisopnames vooral plaatsvinden onder ongevaccineerde personen

COVID-19 vaccination reduces transmission

Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).

Nearly 85% of people aged 18 and over have had at least one vaccination

The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.

Meisje meldt zich bij GGD vaccinatielocatie Leiden

Hospital admissions appear to have peaked, 44% fewer positive COVID-19 tests

541 new COVID-19 hospital admissions were reported last week, 23 fewer than in the week before, when 564 people with COVID-19 were admitted to hospital.

Changed indicative magnetic field zones around overhead high-voltage lines

RIVM has updated the 2005 grid map (Netkaart) showing the overhead high-voltage lines in the Netherlands.

INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity

RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.

RIVM on shortlist Best Government Organisation of the Year 2018

The National Institute for Public Health and the Environment (RIVM) has made the shortlist for the 2018 election for best government organisation of the year.

RIVM supports WHO in national capacity building for measuring foodborne disease burden

RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.

Rapid developments in modern biotechnology are a challenge for risk assessment

Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.

Meningococcal disease serious, but still rare

Meningococcal disease is a disease caused by a bacterium, the meningococcus. There are several types of this bacterium. In most cases, it does not make you ill.